Skip to main content
. 2017 Sep 21;12(9):e0183160. doi: 10.1371/journal.pone.0183160

Table 2. Quality of included studies.

Study Quality Design type Blinded pre/post Attrition (%)
Aldred 2004 [25] Good RCT Yes 12%
Dawson 2010 [27] Good RCT Yes 10%
Green 2010 [31] Good RCT Yes 4%
Howlin 2007 [35] Low RCT No 1%
Solomon 2014 [45] Good RCT Yes 12%
Akshoomoff 2004 [23] Good CS Yes 9%
Anderson 2014 [11] Low CS No 47%
Ben Itzchak 2009 [17] Uncertain CS No Not reported
Brian 2008 [26] Uncertain CS Yes Not reported
Chawarska 2009 [18] Uncertain CS No Not reported
Chawarska 2014 [19] Uncertain CS Not reported Not reported
Dereu 2012 [28] Good CS Not reported 5%
Di Renzo 2015 [21] Uncertain CS Not reported Not reported
Freitag 2012 [29] Uncertain CS No Not reported
Gammer 2015 [22] Good CS Not reported 2%
Gotham 2012 [30] Uncertain CS Not reported Not reported
Guthrie 2013 [32] Uncertain CS No Not reported
Gutstein 2007 [33] Low CS Not reported 25%
Hobson 2015 [34] Uncertain CS Yes, partly Not reported
Kleinman 2008 [12] Low CS No Not reported
Klintwall 2015 [36] Good CS Not reported 12%
Landa 2013 [13] Good CS 22 2%
Lerna 2014 [24] Low CS Yes 22%
Lord 2006 [37] Good CS Not reported 10%
Lord 2012 [38] Uncertain CS No Not reported
Louwerse 2015 [39] Low CS Yes 26%
Macari 2012 [40] Uncertain CS Yes Not reported
Messinger 2015 [15] Good CS Not reported 14%
Mosconi 2009 [41] Low CS Not reported 49%
Ozonoff 2014 [20] Uncertain CS Not reported Not reported
Ray-Subramanian 2012 [42] Uncertain CS Not reported Not reported
Richler 2010 [43] Uncertain CS No info Not reported
Shumway 2012 [44] Low CS Indep assessments 56%
Szatmari 2015 [46] Low CS Not reported 30%
Thurm 2015 [47] Uncertain CS Not reported Not reported
Turner 2007 [48] Good CS Not reported 17%
van Daalen 2009 [16] Uncertain CS Not reported Not reported
Venker 2014 [49] Good CS Not reported 9%
Vivanti 2014 [50] Good CS No 2%
Zachor 2007 [51] Uncertain CS Not reported Not reported

Studies are listed by design type. CS–prospective cohort study; RCT–randomised controlled trial.